Last reviewed · How we verify
Simvastatin combined with Amlodipine besylate
At a glance
| Generic name | Simvastatin combined with Amlodipine besylate |
|---|---|
| Sponsor | Third Military Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Statin Combined with Amlodipine Treats Primary Aldosteronism (PHASE4)
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) (PHASE3)
- Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: